TEVA Form 144: Ordinary Shares Listed for Sale

TEVA: A Form 144 filing lists ordinary shares to be sold through Citigroup Global Markets on 05/14/2026.

Rhea-AI Filing Summary

TEVA: A Form 144 filing lists ordinary shares to be sold through Citigroup Global Markets on 05/14/2026. The filing references a Restricted Share Unit Award Vesting dated 05/14/2025 and shows numeric entries including 41,658, 85,849, and 1,482,366.60.

Insights

Securities Compliance Counsel

Form 144 lists ordinary shares for sale via Citigroup on 05/14/2026.

The filing records ordinary shares offered through Citigroup Global Markets and cites a Restricted Share Unit Award Vesting dated 05/14/2025. Quantities shown include 41,658 and 85,849, with 1,482,366.60 also displayed.

These entries are administrative disclosures under resale rules; subsequent public filings or broker reports would show whether the listed shares were actually sold. Review of transaction confirmations or subsequent SEC filings will provide final disposition details.

Key Figures

Broker-listed numeric entry: 41,658 Numeric entry (appears monetary): 1,482,366.60 RSU-related quantity: 85,849 +2 more

5 metrics

Broker-listed numeric entry 41,658 Shown under Securities Information line

Numeric entry (appears monetary) 1,482,366.60 Displayed alongside broker and securities information

RSU-related quantity 85,849 Listed with 'RESTRICTED SHARE UNIT AWARD VESTING' dated <date>05/14/2025</date>

Date for sale listing 05/14/2026 Appears next to 'Securities To Be Sold' and broker line

RSU vesting date 05/14/2025 Appears with 'RESTRICTED SHARE UNIT AWARD VESTING' entry

Key Terms

RESTRICTED SHARE UNIT AWARD VESTING, ORDINARY SHARES, COMPENSATION

3 terms

RESTRICTED SHARE UNIT AWARD VESTING financial

"RESTRICTED SHARE UNIT AWARD VESTING | TEVA PHARMACEUTICAL INDUSTRIES LIMITED"

ORDINARY SHARES financial

"ORDINARY SHARES | CITIGROUP GLOBAL MARKETS 390 GREENWICH ST NEW YORK NY 10013"

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

COMPENSATION regulatory

"05/14/2025 | RESTRICTED SHARE UNIT AWARD VESTING | ... | COMPENSATION"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does TEVA's Form 144 list?

It lists ordinary shares proposed for sale through Citigroup Global Markets. The filing shows numeric entries 41,658, 85,849, and 1,482,366.60, and references a Restricted Share Unit award vesting date of 05/14/2025.

Does the filing show when the sale will occur for TEVA?

The filing shows a broker entry dated 05/14/2026 for the securities to be sold. It also references a vesting date of 05/14/2025; further timing or sale completion details are not contained within these entries.

What is the role of Citigroup in the TEVA Form 144?

Citigroup Global Markets is listed as the broker handling the reported transaction. The entry pairs the broker name with the securities line for ordinary shares and the date 05/14/2026 shown in the filing.

What does 'Restricted Share Unit Award Vesting' mean in this filing?

The phrase indicates a compensation-related award that vested on 05/14/2025. The filing pairs that vesting event with ordinary shares and numeric entries such as 85,849, suggesting those shares relate to compensation vesting.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/14/2026 - 04:02 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002062834
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	TEVA PHARMACEUTICAL INDUSTRIES LTD
SEC File Number	001-16174
Address of Issuer	TEVA PHARMACEUTICAL INDUSTRIES LIMITED 124 DVORA HANEVI'A ST. TEL AVIV ISRAEL 6944020
Phone	972 (3) 914-8213
Name of Person for Whose Account the Securities are To Be Sold	Lippman Evan
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	EXECUTIVE VP BUSINESS DEVELOPMENT

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
ORDINARY SHARES	CITIGROUP GLOBAL MARKETS 390 GREENWICH ST NEW YORK NY 10013	41658	1482366.60	1164426972	05/14/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
ORDINARY SHARES	05/14/2025	RESTRICTED SHARE UNIT AWARD VESTING	TEVA PHARMACEUTICAL INDUSTRIES LIMITED			85849	05/14/2026	COMPENSATION

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	SHARES WERE SOLD PURSUANT TO COMPLY WITH RULE 10B51 C FROM A PLAN DATED NOVEMBER 10 2025. THE SHARES WERE SOLD TO COVER OBLIGATIONS FROM VESTING AND SETTLEMENT OF EQUITY AWARDS
Date of Notice	05/14/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	11/10/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	CONFORMED SIGNATURE ON FILE
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)